Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-10-012336
Filing Date
2010-08-06
Accepted
2010-08-06 16:41:58
Documents
1
Period of Report
2010-08-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3427
  Complete submission text file 0001179110-10-012336.txt   5211
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address IMCLONE SYSTEMS INCORPORATED 180 VARICK STREET, 6TH FLOOR NEW YORK NY 10014
Business Address IMCLONE SYSTEMS INCORPORATED 180 VARICK STREET, 6TH FLOOR NEW YORK NY 10014 6466385078
BAILEY MICHAEL P (Reporting) CIK: 0001255856 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 10998889